Atrial fibrillation is the most common sustained cardiac arrhythmia and a leading modifiable risk factor for stroke. Rate control, rhythm control, and anticoagulation with direct oral anticoagulants form the triad of management, with catheter ablation increasingly used for symptom control and rhythm restoration. Emerging data on early rhythm control and AF screening strategies continue to refine guideline recommendations.
Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic Challenge
Atrial fibrillation patients face complex cardio-kidney-metabolic risks, demanding integrated care. Policy and reimbursement hurdles complicate CKM clinic establishment.
Atrial Fibrillation Complexity: How Reliable is Registry Data?
Patients with atrial fibrillation often present with a complex interplay of cardio-kidney-metabolic conditions, but large registry data can oversimplify these interactions. Clinicians should interpret such observational findings cautiously, especially when ...